Get the Stockscreener App
14.71
4.11%
-0.63
Si Bone Inc stock is traded at $14.71, with a volume of 398.18K.
It is down -4.11% in the last 24 hours and down -7.08% over the past month.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$15.34
Open:
$15.25
24h Volume:
398.18K
Relative Volume:
0.76
Market Cap:
$649.67M
Revenue:
$150.71M
Net Income/Loss:
$-40.85M
P/E Ratio:
-14.56
EPS:
-1.01
Net Cash Flow:
$-25.98M
1W Performance:
-6.90%
1M Performance:
-7.08%
6M Performance:
-10.03%
1Y Performance:
-13.32%
1-Day Range:
$14.71
$15.40
1-Week Range:
$14.71
$16.36
52-Week Range:
$12.49
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
14.71 | 677.50M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
SIBN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
First Eagle Investment Management LLC Has $7.13 Million Stock Position in SiBone $SIBN - MarketBeat
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - GlobeNewswire Inc.
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SIBN PE Ratio & Valuation, Is SIBN Overvalued - Intellectia AI
SIBN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SIBN SEC FilingsSi-Bone 10-K, 10-Q, 8-K Forms - Stock Titan
Why (SIBN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SI-BONE, Inc. (SIBN) Stock Analysis: Strong Buy Ratings Signal 57.73% Potential Upside - DirectorsTalk Interviews
Smith+Nephew signs distribution agreement with SI-BONE - MedTech Intelligence
Aug Technicals: What is the next catalyst for SI BONE Inc2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partne - The National Law Review
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partnership to Expand Access For Veterans & Wounded Warriors - EIN Presswire
SI‑BONE (SIBN) Losses Narrow In Q4 And Test Bearish Narratives On Profit Path - simplywall.st
SI-BONE, Inc. (NASDAQ:SIBN) Q4 2025 Earnings Call Transcript - Insider Monkey
SI-Bone (SIBN) Submits Automatic Mixed Securities Shelf Filing - GuruFocus
Si-Bone files for mixed shelf size not disclosed - marketscreener.com
Si-Bone Files For Mixed Shelf Size Not Disclosed - TradingView
Si-Bone inks 50,000-square-foot lease in San Jose - The Business Journals
SI-BONE Q4 2025 slides: profitability milestone as revenue tops $200M By Investing.com - Investing.com South Africa
SI-BONE (NASDAQ: SIBN) files shelf to register common, preferred, debt and warrants - Stock Titan
SI-BONE (SIBN) 2025 10-K shows narrowing losses and $3.5B+ market - Stock Titan
TD Cowen Maintains Buy Rating for SIBN, Raises Price Target | SI - GuruFocus
Truist raises SI-BONE stock price target on strong quarter By Investing.com - Investing.com Australia
Truist raises SI-BONE stock price target on strong quarter - Investing.com Nigeria
SiBone (NASDAQ:SIBN) Shares Gap Up on Earnings Beat - MarketBeat
SI-BONE, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Truist Securities Adjusts Price Target on SI-BONE to $24 From $23, Maintains Buy Rating - marketscreener.com
SI-Bone: Early Profitability and 2026 Growth Catalysts Underpin Buy Rating and $22 Price Target - TipRanks
SI-BONE revenue up 15% to USD 56.3M in Q4 2025 - Medical Buyer
Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio - Yahoo Finance
SI-BONE Inc (SIBN) Q4 2025 Earnings Call Highlights: Record Reve - GuruFocus
SiBone Q4 2025 Earnings Call Transcript - MarketBeat
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
SI-BONE Q4 2025 slides: profitability milestone as revenue tops $200M - Investing.com
Earnings Call Summary | Si-Bone(SIBN.US) Q4 2025 Earnings Conference - 富途牛牛
SI-BONE (SIBN) Q4 2025 Earnings Call Transcript - The Globe and Mail
SI-BONE Inc reports results for the quarter ended December 31Earnings Summary - TradingView
SiBone Q4 Earnings Call Highlights - Yahoo Finance
Smith & Nephew (SNN) Strengthens Portfolio with SI-Bone Agreemen - GuruFocus
Earnings call transcript: Si-Bone Q4 2025 reports strong revenue growth and EPS beat - Investing.com
SI-BONE (SIBN) Reports Solid Q4 Revenue and Projects Ongoing Gro - GuruFocus
Si-Bone: Q4 Earnings Snapshot - KVUE
SI-BONE Q4 Loss Narrows, Revenue Rises - marketscreener.com
Si-Bone: Fourth Quarter Financial Overview - Bitget
SI-BONE Inc. (SIBN) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
SiBone (NASDAQ:SIBN) Announces Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat
SI-BONE Posts Record 2025 Results and Strong 2026 Outlook - TipRanks
Medicare may pay $4,136 extra per case for iFuse TORQ TNT - Stock Titan
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance - The Manila Times
Anshul Maheshwari named COO while retaining CFO role at SI-BONE - TradingView
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):